Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

by Lina Nordquist, Fredrik Palm, Bradley T Andresen
Published 2008-09-01

The β-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin

by Mengbing Chen, Sherry Liang, Ayaz Shahid, Bradley T. Andresen, Ying Huang
Published 2020-01-01

Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors.

by Kristan H Cleveland, Sherry Liang, Andy Chang, Kevin M Huang, Si Chen, Lei Guo, Ying Huang, Bradley T Andresen
Published 2019-01-01

The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.

by Catherine E Erickson, Rukhsana Gul, Christopher P Blessing, Jenny Nguyen, Tammy Liu, Lakshmi Pulakat, Murat Bastepe, Edwin K Jackson, Bradley T Andresen
Published 2013-01-01

Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention

by Mengbing Chen, Md Abdullah Shamim, Ayaz Shahid, Steven Yeung, Bradley T. Andresen, Jeffrey Wang, Vijaykumar Nekkanti, Frank L. Meyskens, Kristen M. Kelly, Ying Huang
Published 2020-11-01

In silico prediction of ARB resistance: A first step in creating personalized ARB therapy.

by Shane D Anderson, Asna Tabassum, Jae Kyung Yeon, Garima Sharma, Priscilla Santos, Tik Hang Soong, Yin Win Thu, Isaac Nies, Tomomi Kurita, Andrew Chandler, Abdelaziz Alsamarah, Rhye-Samuel Kanassatega, Yun L Luo, Wesley M Botello-Smith, Bradley T Andresen
Published 2020-11-01